MWM
BIIB icon

Massachusetts Wealth Management’s Biogen BIIB Stock Holding History

Massachusetts Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$583K Buy
3,180
+181
+6% +$33.4K 0.25% 79
2025
Q4 		$528K Buy
2,999
+125
+4% +$20.4K 0.25% 79
2025
Q3 		$403K Hold
2,874
– – 0.2% 82
2025
Q2 		$361K Buy
2,874
+115
+4% +$14.3K 0.2% 78
2025
Q1 		$378K Buy
2,759
+19
+0.7% +$2.72K 0.26% 70
2024
Q4 		$419K Sell
2,740
-135
-5% -$22.8K 0.26% 77
2024
Q3 		$557K Sell
2,875
-25
-0.9% -$5.23K 0.35% 72
2024
Q2 		$672K Sell
2,900
-50
-2% -$10.9K 0.45% 70
2024
Q1 		$636K Sell
2,950
-300
-9% -$70.3K 0.45% 69
2023
Q4 		$841K Buy
3,250
+50
+2% +$12.3K 0.68% 56
2023
Q3 		$822K Sell
3,200
-50
-2% -$13.4K 0.76% 54
2023
Q2 		$926K Buy
3,250
+175
+6% +$52.1K 0.89% 50
2023
Q1 		$855K Sell
3,075
-325
-10% -$89.9K 0.88% 48
2022
Q4 		$989K Buy
+3,400
New +$960K 0.96% 46

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Wealth Management's BIIB Position: Q1 2026 in Review

Massachusetts Wealth Management increased its Biogen (BIIB) stake by 6% in Q1 2026, buying an estimated $33.4K and bringing the position to 3,180 shares worth $583K. The position accounts for 0.25% of the portfolio, ranked #79.

Massachusetts Wealth Management first reported a position in BIIB in Q4 2022 and has held it in 14 quarters since. The position peaked at $989K in Q4 2022. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Massachusetts Wealth Management held 3,180 shares of Biogen worth $583K as of Q1 2026.
  • Massachusetts Wealth Management bought 181 Biogen shares in Q1 2026, an estimated $33.4K.
  • Biogen made up 0.25% of Massachusetts Wealth Management's portfolio in Q1 2026, its #79 holding.
  • Massachusetts Wealth Management first reported a position in Biogen in Q4 2022 and has held it in 14 quarters since.
  • Massachusetts Wealth Management's Biogen position peaked at $989K in Q4 2022.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.